Captor Therapeutics Spolka Akcyjna reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net loss was PLN 43.32 million compared to PLN 20.84 million a year ago. Basic loss per share from continuing operations was PLN 10.29 compared to PLN 5.01 a year ago.